Archive for October, 2018

Public Demand for CBD Creates New Research Opportunities

By MHS Staff / October 26, 2018 / Hemp & CBD News

There’s been a lot of buzz around CBD these days, even before rumors that Coca-Cola is considering a CBD-infused beverage. The CBD industry has doubled in size in the last two years, and one cannabis research firm estimates that the cannabis market will reach $20 billion by 2020…

FDA Suggests CBD be Changed to Schedule 5 Substance

By MHS Staff / October 05, 2018 / Hemp & CBD News

In a newly released memo, the U.S. FDA suggested cannabidiol (CBD) be removed from the Controlled Substances Act to Schedule 5 like over the counter meds…

Get Social!

Follow us on social media and sign up for our newsletter to get exclusive deals, content and info!


© Copyright 2020, Mountain High Select. All Rights Reserved. Website by: 420WebsiteDesign.com

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction. ALL SALES ARE FINAL.